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ABSTRACT Fluorocarbongases (gFCs)were found to inhibit the liquid-expanded (LE)/liquid-condensed (LC) phase transition of
dipalmitoyl phosphatidylcholine (DPPC) Langmuirmonolayers. The formation of domains of an LCphase, which typically occurs in
the LE/LC coexistence region upon compression of DPPC, is prevented when the atmosphere above the DPPC monolayer is
saturatedwith a gFC.When contactedwith gFC, theDPPCmonolayer remains in the LEphase for surface pressures lower than38
mNm1, asassessedbycompression isothermsandﬂuorescencemicroscopy (FM).Moreover, gFCscan induce thedissolutionof
preexisting LC phase domains and facilitate the respreading of the DPPC molecules on the water surface, as shown by FM and
grazing incidence x-ray diffraction. gFCs have thus a highly effective ﬂuidizing effect on the DPPC monolayer. This gFC-induced
ﬂuidizing effect was compared with the ﬂuidizing effect brought about by a mixture of unsaturated lipids and proteins, namely the
two commercially available lung surfactant substitutes, Curosurf and Survanta, which are derived from porcine and bovine lung
extracts, respectively. The candidate FCs were chosen among those already investigated for biomedical applications, and in
particular for intravascular oxygen transport, i.e., perﬂuorooctyl bromide, perﬂuorooctylethane, bis(perﬂuorobutyl)ethene, per-
ﬂuorodecalin, and perﬂuorooctane. The ﬂuidizing effect is most effective with the linear FCs. This study suggests that FCs,
whose biocompatibility is well documented, may be useful in lung surfactant substitute compositions.
INTRODUCTION
This work reports an investigation of the effects of the
adsorption of ﬂuorocarbon gases (gFCs) on the structure and
behavior upon compression and expansion of a dipalmitoyl
phosphatidylcholine (DPPC) monolayer, taken as a simpli-
ﬁed model of lung surfactant (LS), with the objective of
determining the potential of ﬂuorocarbons (FCs) for new LS
compositions. Due to their high biological inertness, re-
markable ability to solubilize oxygen, and extremely low
solubility in water, FCs have been investigated for various
biological applications (1), in particular for intravascular
oxygen transport (2) and for the stabilization of gaseous
microbubbles used as contrast agent in ultrasound imaging
(3). Partial liquid ventilation (PLV) with FCs has been
explored as a treatment of acute respiratory distress syn-
drome (ARDS). Improved oxygenation and lung compliance
were achieved in preterm animal models (4) as well as in
premature infants (5,6). FC-based PLV was also reported to
have an antiinﬂammatory effect in the alveolar environment
of trauma patients (7). The fact that FCs attenuate the
proinﬂammatory and procoagulatory responses of activated
monocytes and of alveolar macrophages may contribute to
the protective role of FCs in injuries associated with local
activation of inﬂammatory processes (8). Delivery of
vaporized FCs to oleic acid-injured ARDS sheep resulted
in signiﬁcant and sustained improvements of gas exchange
and of lung compliance (9,10). Although these results sug-
gest that FCs may be useful in pulmonary disease therapy,
no study aiming at determining the inﬂuence of FCs on LS or
LSmodels appears to have been reported so far, to our knowl-
edge.
The native LS is a complex mixture of lipids and proteins
that forms a monolayer at the alveolus/air interface of mam-
malian species (11,12). LS is secreted into the alveolar space
by epithelial type II pneumocytes via exocytosis (13,14). It
contains several lipids, primarily DPPC, small fractions of
polyunsaturated fatty-acid-containing phospholipids (PUFA-
PL), anionic PLs such as phosphatidylglycerols (PGs), neu-
tral lipids such as diacyl- and triacylglycerols, free fatty acids
such as palmitic acid (PA), plasmalogens, and cholesterol
(15). LS also contains four speciﬁc proteins (SP-A, SP-B,
SP-C, and SP-D). One key role of LS is to form a monolayer
that lowers the air/alveoli surface tension upon compression
(i.e., during expiration), reduces the work of breathing, and
respreads easily on expansion (i.e., during inspiration) (16,17).
The LS function has been described by the ‘‘squeeze out’’
model (18). Upon compression, the minor components (pre-
dominantly nonphosphatidylcholine compounds) are squeezed
out from the monolayer, which results in an enrichment of
the monolayer in phosphatidylcholine compounds. Surface
tension is then reduced and alveolar collapse is prevented.
However, the physicochemical properties of the major
surfactant-PL fraction were not in accordance with the
predicted requirements of this model (19). A new concept
SubmittedNovember 1, 2005, and accepted for publication January 10, 2006.
Address reprint requests to Dr. Marie Pierre Krafft, Institut Charles Sadron
(CNRS, UPR 22), 6 rue Boussingault, 67083 Strasbourg Cedex, France.
Tel.: 33-3-88-41-40-60; Fax: 33-3-88-41-40-99. E-mail: krafft@ics.u-strasbg.fr.
 2006 by the Biophysical Society
0006-3495/06/05/3184/09 $2.00 doi: 10.1529/biophysj.105.077008
3184 Biophysical Journal Volume 90 May 2006 3184–3192
involving a ‘‘surface-associated reservoir’’ was suggested as
an improved model (20,21). In this model of surfactant
function, layers of LS are folded in the subphase and remain
in contact with the monolayer at the air/liquid interface. One
key role of the minor components of LS is to decrease the
surface viscosity of the monolayer (19). SP-B and SP-C are
small amphiphilic proteins that were recently shown to play
an important role in the surface activity of the LS (22,23).
Recent work has focused on designing lipid mixtures that
combine the surface activity of PLs (and neutral lipids) and
the ﬂuidizing properties of plasmalogens, PUFA-PL, and
SP-B (15).
Although DPPC can generate near-zero surface tension at
the air/water interface during compression, it is a poor LS
when used alone. This is because it tends to form rigid, multi-
lamellar structures in solution and does not adsorb efﬁciently
at the air/water interface. When present at the interface,
DPPC forms a monolayer that is in the semicrystalline liquid-
condensed (LC) state (24). Moreover, DPPC does not respread
upon expansion because of the formation of stable, two-
dimensional crystalline domains at the air/water interface.
Several LS substitutes (for example, Curosurf (Chiesi
Pharmaceutici, Parma, Italy) and Survanta (Ross Laborato-
ries, Columbus, OH)) have been developed and are being
clinically used in the treatment of neonatal respiratory
distress syndrome (NRDS). These replacement LS consist of
puriﬁed preparations of bovine (Survanta) or porcine (Curosurf)
LS. Being natural extracts, these preparations are, however,
not devoid of potential viral contamination and inherent im-
munological risks. Other drawbacks include a costly puriﬁc-
ation procedure and the difﬁculty of achieving batch-to-batch
consistency. Therefore, there is a clear need for alternative
synthetic LS substitutes (25).
We found that FC gases have a strong effect on the
physical state of DPPC Langmuir monolayers upon com-
pression. Langmuir monolayers provide useful model sys-
tems for studying LS. Great care is necessary when
extrapolating Langmuir monolayer behavior to LS behavior
in vivo. General correlations between in vitro and in vivo
behavior start, however, to emerge (26). The behavior of
surfactants in monolayers is characterized by surface pres-
sure – molecular area (p – A) compression isotherms. Com-
pression isotherms of DPPC monolayers were measured
under an atmosphere saturated with various gFCs. Fluores-
cence microscopy (FM) and grazing incidence x-ray diffrac-
tion (GIXD) were used to determine the presence, morphology,
and degree of order of the organized domains within the
monolayers. Because FCs have low intermolecular cohe-
siveness, their vapor pressures are high with regard to their
molecular weights (27). The FCs selected for this study,
perﬂuorooctyl bromide (PFOB), perﬂuorooctylethane (PFOE),
bis(perﬂuorobutyl)ethene (F-44E), perﬂuorodecalin (FDC),
and perﬂuorooctane (PFO), were chosen among those most
thoroughly investigated for biomedical applications, in par-
ticular for intravascular oxygen transport (2). Both the ability
of gFCs to prevent the formation of crystalline DPPC domains
and their ability to dissolve such domains once formed
were determined. We have also compared the behavior of
DPPC monolayers contacted with gFCs with that of mono-
layers of the commercial LS substitutes Curosurf and Survanta.
MATERIALS AND METHODS
Materials
PFOB and PFOE were kindly provided by Alliance Pharmaceutical (San
Diego, CA), FDC by Air Products (Allentown, PA), and F-44E by DuPont
(Wilmington, DE). PFO and L-a-1,2-dipalmitoyl-sn-3-glycero-phosphati-
dylcholine (DPPC, purity .99%) were purchased from Sigma (St. Louis,
MO). Samples of Curosurf and Survanta were a gift from Prof. J. Messer
(Service de Ne´onatalogie, Hoˆpital de Hautepierre, Strasbourg, France).
Water was puriﬁed using aMillipore system (pH¼ 5.5; surface tension: 72.1
mN m1 at 20C, resistivity: 18 MV cm). The ﬂuorescent dye (2-[6-(7-
nitrobenz-2-oxa-1,3-diazol-4-yl)amino] hexanoyl-1-hexadecanoyl-sn-glycero-
3-phosphocholine, NBDC6-HPC) was purchased from Molecular Probes
(Eugene, OR).
Methods
Compression of DPPC monolayers under FC gases
Surface pressure, p, versus molecular area, A, isotherms were recorded on a
Langmuir minitrough (Riegler & Kirstein, Potsdam, Germany) equipped
with two movable barriers (speed: 2.0 mm min1, which corresponds to a
reduction of the total area of 3% min1). The surface pressure was measured
using the Wilhelmy plate method. The trough was enclosed in a gas-tight
box (volume ¼ 9 L). The gas-tight box was ﬂushed either with pure N2 or
with N2 saturated with the chosen FC. In the latter case, N2 was allowed to
bubble at room temperature through the liquid FC before being ﬂushed into
the gas-tight box. The ﬂow rate of the gas phase (N2 or N2 saturated with the
FC) was set to 1.2 L min1 for PFOB, PFOE, F-44E, and FDC and 0.5 L
min1 for PFO. The evaporation rate of these FCs was then;6 mL h1. The
temperature measured inside the gas-tight box was 26C6 0.5C. The errors
on p and Awere estimated to be6 1 mNm1 and6 1 A˚2, respectively. The
molecular formula and physical characteristics of the FCs investigated are
collected in Table 1. Spreading solutions of DPPC (1.0 mmol L1 for
TABLE 1 Structural formula and physical characteristics
of the FCs investigated (from Riess (2))
Structural formula
Code
name
(MW)
Boiling
point
(C)
Vapor
pressure
(torr, 37C)
*CST in
hexane
(C)
CF3(CF2)7Br PFOB (499) 143 10.5 20
CF3(CF2)7CH2CH3 PFOE (448) 164 11.5 8
FDC (462) 142 13.5 22
CF3(CF2)3CH¼CH(CF2)3CF3 F-44E (464) 150 12.5 19.5
CF3(CF2)6CF3 PFO (438) 102 52–64
y
*Critical solution temperature (CST).
yNot determined.
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minitrough experiments and 2.0 mmol L1 for GIXD experiments) were
prepared in chloroform (analytical grade). A total of 15mL of DPPC solution
was spread on the water surface.
Compression of monolayers of Curosurf and Survanta
Curosurf and Survanta are available in the form of aqueous dispersions. The
samples were frozen to 80C, transferred to the lyophilizer (Flexi-Dry,
FTS Systems Inc., Stone Ridge, NY) and lyophilized at30C and 20 Pa for
18 h. The lyophilized samples were then solubilized in chloroform at the
concentration of 1 mg mL1. No correction was made to take into account
the amount of salts present in Curosurf and Survanta. In addition to the lipids
and proteins (Table 2), which have a minimal solubility in water, Curosurf
and Survanta contain several components that are soluble in the subphase.
As a consequence, the values of the extrapolated areas of the isotherms
depend on the amount deposited on the water surface. A total of 12 mL
of each surfactant solution was spread on the surface.
Fluorescence microscopy
FMwas achievedwith the above balance equippedwith an Olympus (Tokyo,
Japan) ﬂuorescence microscope (203 power objective) mounted on an x, y
translation stage to allow scanning of the trough over different regions. An
Olympus 100 W high-pressure mercury lamp was used for excitation. A
dichroic mirror/barrier ﬁlter assembly was used to ﬁlter and direct the
excitation light onto themonolayer (450–490 nm) and to ﬁlter out the emitted
ﬂuorescence (520 nm). The emitted ﬂuorescence was collected by the
objective and detected via a Hamamatsu (Hamamatsu City, Japan) intensiﬁed
camera. The microscope was linked to the gas-tight box of the trough through
an extensible gusset, allowing easy control of the partial pressure of the FC.
The surface pressure was kept constant during FM experiments. The ﬂuores-
cent dyeNBDC6-HPCwasused at a lipidmole ratio of 1% (13 10
5mol L1).
Grazing incidence x-ray diffraction
GIXD experiments were achieved at the D41B beamline of the LURE-DCI
synchrotron source (Orsay, France). The x-ray wavelength l ¼ 1.646 A˚ of
the incoming x-ray beam was selected using a focusing Ge (111) mono-
chromator. The monocrystalline surface of a Ge plate (Æ111æ) is used to select a
monochromatic beam of wavelength 1.646 A˚ from the white synchrotron
beam (28). The grazing angle of incidence ui ¼ 2.08 mrad was set slightly
below the critical angle for total external reﬂection of the x-rays at the air/water
interface (;2.8 mrad at 1.646 A˚). For the acquisition of the diffracted
intensity, we used a new setup composed of a two-dimensional detector and a
single vertical slit positioned between the sample and the detector (28). The
resulting qxy resolution was 0.007 A˚
1 for the q-range explored here. The
shape of the Bragg rods gave information about the tilt angle t and tilt azimuth
f (29). In the following, the rectangular description of the chain lattice will be
used (30). The diffraction pattern exhibits two peaks. The peak located at low
qxy corresponds to the degenerate [11] and [1] out-of-plane reﬂections, and the
other peak to the [02] in-plane reﬂection. Since the maximum of intensity
along the Bragg rods [11] and [1] is located out of the plane and in the
scattering plane along the Bragg rod [02], the chains are tilted to the nearest
neighbor. Thus, the observed phase is L2d (t 6¼ 0, f ¼ 0), according to the
nomenclature introduced in Kaganer et al. (30).
The Teﬂon Langmuir trough mounted on the diffractometer was
equipped with a movable single barrier. The surface pressure, p, measured
using the Wilhelmy plate method, was kept constant throughout a given
scan. The trough was enclosed in a gas-tight box with Kapton windows
ﬂushed with water-saturated helium. Helium is the only gas that exerts
sufﬁciently low absorption and scattering of the incident and diffracted x-ray
beam to allow measurement of the diffraction of the monolayer at the
interface. It is noteworthy that the diffraction and scattering level by N2 is
too high to enable the diffraction measurement. When appropriate, helium
was saturated with the chosen FC. With this chamber, the partial pressure of
the FC was readily controlled. The temperature was regulated to 20C 6
0.5C. A total of ; 50 mL of DPPC solution were spread on the water
surface. The ﬁlm was compressed stepwise, and Bragg peaks were recorded
at each set pressure step. The total duration of a scan was typically 10 min.
RESULTS
Compressing a Langmuir monolayer of DPPC
under an atmosphere saturated with gFCs
The isotherms of the DPPC monolayer compressed on a pure
water subphase in an atmosphere of air or N2 or in an
atmosphere of N2 saturated with PFOB, PFOE, PFO, F-44E,
or FDC are shown in Fig. 1. The whole range of surface
TABLE 2 Compositions of Curosurf and Survanta
Phospholipid and protein components Survanta Curosurf
DPPC* 39 25
PUFA-PL* 6 6 1 26 6 1
Plasmalogens* 1.5 6 0.2 3.8 6 0.1
Cholesterol* 1.5 0.08
SP-By 1.3 6 0.2 3.2 6 0.5
SP-Cy 16.5 6 3.7 10.1 6 1.5
*From Ru¨diger et al. (15). The values are given in mol % of total PLs.
yFrom Bernhard et al. (38). The values are given in micrograms per
micromole of PL.
FIGURE 1 Compression isotherms of DPPC on water under an atmos-
phere of (1) air (25C), (2) N2 (26C), and (3) N2 saturated with various FCs
at 26C. No signiﬁcant difference was observed on the isotherms of the FCs
investigated (see Table 1). The letters (a, b, c, a9, b9, and c9) correspond to
the surface pressures at which the monolayers have been imaged with FM
(see Fig. 2). (Inset) Compression isotherms of DPPC under an atmosphere of
air (dashed line) and under an atmosphere of N2 saturated with gPFOB (solid
line). Near zero surface tensions can be achieved with the DPPC monolayer
contacted with gPFOB.
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pressures, from 0 to 72 mN m1, was investigated (see inset
in Fig. 1). This corresponds to surface tensions from 72 to
0 mN m1 and includes the physiological surface tensions.
When compressed under ambient air (without the gas-tight
box) at 25C 6 0.5C, the DPPC isotherm presented the
characteristic ﬁrst-order transition from the disordered LE
phase to the ordered LC phase (31,32). The phase transition
surface pressure, peq, at a given temperature is a character-
istic quantity for a given lipid in a monolayer on a given
subphase. The peq value determined for DPPC from the
isotherm was ;10 mN m1. This value is in agreement with
the literature, which reports for DPPC on pure water, a peq
value of ;4 mN m1 at 20C shifted by @peq/@T ; 1 1.5
mN m1 K1, until a tricritical point is reached at Tt ;43C
(32). Enclosing the trough in the gas-tight box resulted in an
increase of temperature of ;1C (26C 6 0.5C), which
results in an increase of peq to ;13 mN m1. The LE/LC
coexistence region is identiﬁed by the observation, by FM, of
discrete domains of LC phase within a continuous LE phase
(Fig. 2). When p increases, the LC domains increase in size,
become more numerous, and progressively merge into a con-
tinuous LC phase.
Compressing the DPPC monolayer under a N2 atmosphere
saturated with a gFC changes the phase behavior drastically.
The LE/LC transition at ;13 mN m1 (Fig. 1) disappears.
The compression isotherm is now characterized by two kinks
at;28 and;38 mNm1. Below;38 mNm1, the isotherm
is shifted toward larger molecular areas, which indicates that
FC molecules are incorporated into the DPPC monolayer. It
is also noteworthy that, even at the beginning of the com-
pression, the surface pressure is not zero as in the case of
pure DPPC, but 2–4 mN m1, which also shows that FC
molecules are inserted into the DPPC monolayers.
The transition observed at ;28 mN m1 is no longer of
the LE/LC type, as assessed by the ﬂuorescence images that
are bright and featureless (Fig. 2), not only at ;28 mN m1,
but up to ;35 mN m1 (Fig. 2 c9). This suggests a con-
formational change of the FC molecules inserted in the
DPPC monolayer. For p higher than ;38 mN m1, the
isotherm becomes steeper, and the limiting area (;50 A˚2)
is then very comparable to the limiting area of the DPPC
monolayer compressed in the absence of gFC. This indicates
that the FC molecules are progressively squeezed out on the
top of the DPPC monolayer. At such high surface pressures,
FM images show the presence of very small crystalline
domains, suggesting that the LE/LC transition occurred at
;38 mN m1. However, for these p values, the images are
not focused, probably due to the presence of PFOB mol-
ecules expelled from the DPPC monolayer, which likely
form a thin liquid ﬁlm with small droplets on top of the
monolayer. It is noteworthy that for p higher than 38 mN
m1, i.e., after squeeze out of the FC molecules, only small
LC domains are seen as compared to the essentially con-
tinuous LC phase observed for DPPC under pure N2 at the
same p values. It is likely that the presence of a thin liquid
FC ﬁlm on top of the DPPC monolayer also disorganizes the
DPPC molecules and contributes to the ﬂuidization process
at high surface pressures. Finally, it should be noticed that
the presence of the gFC above the DPPC monolayer does not
destabilize it.
The collapse surface pressure of the DPPC monolayer in
contact with gFC is ;71 mN m1 (see inset in Fig. 1), i.e.,
is identical to the collapse surface pressure of the DPPC
monolayer in the absence of gFC. This means that combi-
nations of DPPC and gFC allow reaching very low surface
tension values, which is necessary if gFCs are to be used in
exogenous LS compositions.
These experiments demonstrate that gFC molecules
interact with DPPC molecules and prevent the formation of
the LC phase until high values of lateral pressure and hence
induce a ﬂuidizing effect in the monolayer.
An important issue with regard to the potential LS replace-
ment application was to ensure that there is no delipidating
effect of gPFOB on the DPPC monolayer. Fig. 3 represents
the compression/expansion isotherms of DPPC in an at-
mosphere of N2 saturated with gPFOB. It shows clearly that
very few DPPC molecules have desorbed from the air/water
FIGURE 2 Fluorescence micrographs of DPPC under pure N2 (left panel)
and of DPPC compressed under an N2 atmosphere saturated with gPFOB in
a gas-tight box (right panel). The images were obtained using the ﬂuorescent
dye NBDC6-HPC, which is preferentially soluble in the disordered regions
of the monolayer (39). As a result, LE regions appear bright, whereas the LC
domains appear dark. The temperature was 26C, and the subphase was pure
water. The lateral pressures were (a) 2 mN m1, (b) 13 mN m1, (c) 20 mN
m1, (a9) 13 mN m1, (b9) 20 mN m1, and (c9) 35 mN m1. The gaseous
FC present above the monolayer prevents the formation of LC domains.
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interface during the compression/expansion cycle. However,
the shape of the expansion isotherm has signiﬁcantly
changed. Although the compression isotherm was charac-
terized by two kinks at 28 and 38 mN m1, only the latter
kink was observed during expansion. The plateau observed
around 38 mN m1 is more clearly visible than during com-
pression, and the expansion isotherm is much more ex-
panded than the compression isotherm. FM images clearly
show the presence of very small crystalline domains for
pressures higher than 38 mN m1 (data not shown). For p
values lower than 38 mN m1, the images were bright and
featureless, demonstrating that the monolayer was in a
homogeneous LE phase (Fig. 2). This conﬁrms that the
LE/LC phase transition occurs at;38 mNm1 for the DPPC
monolayer in contact with gPFOB.
The fact that the kink at 38 mN m1 is much more visible
during expansion than during compression as well as the fact
that the expansion isotherm is much more expanded than the
compression isotherm clearly indicate that PFOB molecules
that were squeezed out to the top of the DPPC monolayer
during the ﬁrst compression are reincorporated into the mono-
layer during expansion. It is not surprising that the change
in orientation of the FC molecules that is evidenced upon com-
pression by the kink at;28mNm1 is no longer visible during
expansion.
We have designed another experiment aimed at detecting
any delipidating effect of the gFC in which the gas-tight box
that had contained gPFOB-saturated N2 was ﬂushed with
pure N2 after the ﬁrst compression/expansion cycle. This
allowed us to thoroughly remove gPFOB (Fig. 3). It was
observed that the compression isotherm of the DPPC mono-
layer after removal of gPFOB is similar to that obtained
when compression was achieved in the absence of gPFOB.
This indicates that the PFOB molecules are easily removed
from the DPPC monolayer by evaporation. It also establishes
that the ﬂuidizing effect of gPFOB is a reversible phenom-
enon. The fact that, during the second compression, the limit-
ing area is nearly identical to that observed during the ﬁrst
compression further indicates that the presence of gPFOB
molecules does not provoke any signiﬁcant loss of DPPC
molecules to the subphase.
Similar results were obtained with the other FCs inves-
tigated. All gFCs interacted with DPPC, thus preventing the
formation of the LC phase and inducing a ﬂuidizing effect in
the monolayer. This ﬂuidizing effect was always reversible;
removal of the gFC by N2 ﬂushing of the gas-tight box
resulted in the restoration of the isotherm of a pure DPPC
monolayer, with the same limiting molecular area, which
further demonstrates that no signiﬁcant amount of DPPC
molecules had been desorbed by the gFC.
Effect of gFCs on preformed LC domains
To assess the effect of gFCs on the DPPC semicrystalline
domains that are already formed, DPPC monolayers were
ﬁrst compressed to 13 mN m1 and gFC-saturated N2 was
then allowed to ﬂow into the gas-tight box that encloses the
trough. The ﬂuorescence images of Fig. 4 clearly show that,
FIGURE 3 Compression isotherms of DPPC (26C) on a pure water
subphase. The ﬁrst compression (solid line) and subsequent expansion
(dotted line) were achieved under an atmosphere of N2 saturated with
gPFOB. gPFOB was then evacuated for 2 h by ﬂushing with N2. The second
compression (dashed line) was obtained under an atmosphere of pure N2.
FIGURE 4 Fluorescence images of a DPPCmonolayer compressed at 13mN
m1 under N2 (upper left). At time t, the atmosphere of N2 above the monolayer
was saturated with gPFOB. One can see that the LC domains progressively
disappear over time. After 7 min, the monolayer is totally ﬂuidized.
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3 min after the introduction of gPFOB, the LC domains have
become signiﬁcantly smaller. After 7 min, these domains
have totally disappeared, indicating that the DPPC mono-
layer has become totally ﬂuid. When the DPPC monolayer
was contacted with gPFOE at 13 mN m1, total ﬂuidization
of the monolayer was observed after 5 min (Fig. 5).
The ﬂuidizing capacity of gFCs depends somewhat on the
structure of the FC. PFO and PFOE were the most efﬁcient in
this respect, inducing total ﬂuidization within ;5 min. The
effect of F-44 E was comparable to that of PFOB (total
ﬂuidization in ;7 min). The effect was slower with FDC
(ﬂuidization required ;10 min). The lesser ﬂuidizing capac-
ity of the bicyclic FDC may be assigned to lesser afﬁnity for
hydrocarbon oils, as indicated by a higher critical solubility
temperature (CST) in hexane (Table 1) and to its globular,
bulky molecular shape.
FM provides information on a local scale. Small crystal-
line domains present at the interface may escape from the
investigation ﬁeld and not be taken into account. To have a
deﬁnitive, independent assessment of any possible crystal-
line regions present in the monolayer, we performed GIXD
using synchrotron radiation. An x-ray beam that hits the
surface of water at an incidence lower than the critical angle
of water (;2.5 mrad) is totally reﬂected. Under these con-
ditions, an evanescent wave is formed that is scattered by the
monolayer. If the monolayer is ordered (i.e., crystalline), the
wave is diffracted and Bragg peaks are obtained. GIXD thus
provides global information on the zones of the monolayer
that are ordered.
Fig. 6 a shows the integrated diffracted intensity (I/I0) as
a function of the in-plane component of the scattering wave
vector (qxy) of a DPPC monolayer compressed at 20 mN m
1.
At this surface pressure, two Bragg peaks were obtained,
indicating a rectangular unit cell (NN tilted, L2d phase). The
calculated area per chain of ;23 A˚2 and the tilt angle ob-
tained from Bragg rod analysis are in agreement with pub-
lished data for DPPC. When the He atmosphere was saturated
with gPFOB, the diffraction peaks disappeared within a
few minutes (Fig. 6 b), establishing the dissolution of the LC
domains and the rapid respreading of the DPPC molecules.
When pure He was subsequently allowed to ﬂow again
into the gas-tight box, the compression of the DPPC mono-
layer being maintained at 20 mN m1, the two diffraction
peaks characteristics of DPPC slowly reappeared, establish-
ing the reformation of the LC domains. This indicates that
PFOB molecules are adsorbed at the DPPC monolayer and
inhibit the crystallization of these DPPC molecules. When
the ﬂow of gPFOB is stopped, the PFOB molecules adsorbed
at the interface are removed by evaporation and are then evac-
uated with the He ﬂow.
It is noteworthy that total ﬂuidization has not been
obtained in the case of FDC (Fig. 7). The DPPC peak at
FIGURE 5 Fluorescence images of a DPPC monolayer compressed at 13
mN m1 under N2 (upper left). At time t, the atmosphere of N2 above the
monolayer was saturated with gPFOE. The LC domains rapidly disappear.
After 5 min, the monolayer is totally ﬂuidized.
FIGURE 6 Intensity of the diffracted grazing x-rays, I/I0, as a function
of the in-plane vector, qxy. For GIXD experiments, the DPPC monolayer
was compressed under a helium atmosphere to reduce x-ray scattering.
When compressed at 20 mNm1, the DPPC monolayer shows the two Bragg
peaks characteristic of the tilted LC phase of DPPC at 1.42 and 1.51 A˚1
(curve a). When the He atmosphere is saturated with gPFOB (curve b),
the peaks disappear rapidly, establishing the dissolution of the crystalline LC
domains and the rapid uniform respreading of the DPPC molecules.
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qxy ¼ 1.51 A˚1 is less intense but still visible even if the
gas-tight box of the trough has been saturated with gFDC for
over 1 h. This indicates that parts of the monolayer still retain
some weak organization. The fact that FDC is not as efﬁcient
as the other FCs with respect to the DPPC monolayer ﬂu-
idization may be ascribed to the globular shape of the FDC
molecule, which is expected to be less favorable to insertion
between the hydrophobic fatty chains of DPPC than the
linear shape of the other FCs investigated.
Comparison with Curosurf and Survanta
The compression isotherms of monolayers of the replace-
ment LS Curosurf and Survanta are shown on Fig. 8. The
Curosurf and Survanta formulations contain components that
are soluble in the subphase. The nature and exact amounts of
these soluble compounds being unknown, no relationship
can be established between the deposited amount and the
apparent area per molecule. However, the shapes of the iso-
therms (steep versus expanded) are characteristic of the
degree of organization and ﬂuidity of the monolayer. It is
clearly seen that the compression isotherm of Survanta is
steeper than that of Curosurf, in agreement with Ivanova et al.
(33), demonstrating a lower compressibility (comparable to
that of the LC phase of DPPC). A slight kink is observed for
Curosurf at;28 mN m1, and the isotherm becomes steeper
at higher surface pressures. FM images (Fig. 9, left panel)
indeed show that the Curosurf monolayer is in the ﬂuid LE
state, except at the highest lateral pressures (i.e., 45 mN
m1), for which some small crystalline domains can be ob-
served (Fig. 9 c). By contrast, deﬁnite crystalline domains are
already seen in the Survanta monolayer at low surface pres-
sures, actually even at zero surface pressure for A ¼ 80 A˚2
(Fig. 9 a9). The number of these domains increases rapidly
with p, until they practically form a continuous LC phase at
45 mN m1 (Fig. 9 c9).
The difference in ﬂuidity between Survanta and Curosurf
may be related to the fact that the former has the lowest content
in components that decrease the viscosity of the monolayer,
such as plasmalogens, PUFA-PL, and SP-B (Table 2). In
addition, Survanta has the highest concentration in disaturated
FIGURE 7 In contrast with Fig. 6, the Bragg peaks characteristic of the
LC domains of DPPC (a) did not disappear totally when gaseous FDC was
introduced in the gas-tight box instead of PFOB (b).
FIGURE 8 Compression isotherms of (1) Curosurf and (2) Survanta as
compared to those of pure DPPC compressed under N2 (3) and DPPC com-
pressed under N2 1 gPFOB (4) (at 26C).
FIGURE 9 Fluorescence images of a Curosurf monolayer (left panel)
compressed at (a) 10 mN m1, (b) 20 mN m1, and (c) 45 mN m1, and of
a Survanta monolayer (right panel) at (a9) 0 mN m1 (80 A˚2), (b9) 10 mN
m1, and (c9) 45 mN m1.
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PLs that tend to form crystalline islets and in cholesterol that
tends to increase the monolayer’s viscosity (15).
DISCUSSION
To our knowledge, this is the ﬁrst time that such a drastic
change in the physical state of PL monolayers, when con-
tacted with a volatile oil, has been reported. This effect has
been observed with several FCs. Liquid FCs have, among
liquid oils, the highest vapor pressures relative to their mo-
lecular weight. This is a consequence of the liquid’s low
cohesiveness, consequent to the weakness of the van der
Waals interactions between ﬂuorinated chains. The observed
ﬂuidization of the DPPC monolayer may result from the
progressive insertion of FC molecules into the DPPC
monolayer. This may involve a mechanism comparable to
that proposed for hydrocarbon oils contacting PL monolay-
ers (34). It is likely that the FC condenses upon compression
and forms a thin liquid ﬁlm on top of the DPPC molecules.
The FC molecules are reincorporated into the monolayer
upon expansion. The ﬂuidizing effect of gFCs that is
established here results from the inhibition by the gFCs of
the formation of an LC phase and from the fact that an LE
phase is more ﬂuid than a crystalline LC phase.
Improving our understanding of the interactions between
FCs and PL interfaces is a key issue for the medical use of
FCs since several FC-based systems are being developed (1).
One can note the growing interest for gaseous microbubbles
as contrast agents for ultrasound diagnosis (echosonography)
and therapy (3,35). The most recent commercial micro-
bubbles have a shell made of PLs and are osmotically stabilized
by an FC gas (3). A synergistic effect between shell and in-
ternal gas components has recently been demonstrated (36).
We believe that the observations reported here are im-
portant because they suggest that a gFC/PLs combination
could be the basis for the development of new synthetic LS
replacement compositions. One advantage of this new ap-
proach is that the acting components (FC 1 DPPC) are syn-
thetic. Another is that the ﬂuidizing effect induced by gFCs
is highly reproducible. During expansion (inspiration) the
gFC molecules are likely inserted into the monolayer, thus
preventing the formation of crystalline domains of DPPC
and facilitating DPPC respreading. During compression
(expiration), the FC molecules are expelled, leaving a DPPC-
rich monolayer capable of producing near zero surface ten-
sion, but remain readily available, probably as a condensed
thin liquid ﬁlm on top of the DPPC monolayer. We have also
established that the contact of the DPPC monolayer with
gFC does not induce any detectable desorption of the PLs to
the subphase. Such a mechanism of action would not require
a ‘‘reservoir’’ effect provided by folded layers of PLs and
proteins.
Replacing the air/water interface by a gFC-saturated air/
water interface appears to have a signiﬁcant impact on the
adsorption of DPPC molecules at the interface. We have
recently shown that the interfacial tension was much lower at
a gPFOB/water interface than at the air/water interface and
that the kinetics of adsorption of DPPC molecules at the
interface were strongly accelerated (F. Gerber, M. Sanchez-
Dominguez, T. F. Vandamme, and M. P. Krafft, unpub-
lished). We can thus infer that, in vivo, the presence of gFC
in the lung will help recruit DPPC molecules at the alveolar
interface, thus decreasing the interfacial tension and improv-
ing the pulmonary function. This function would be com-
bined and develop a synergy with the LS function, which
will provide a further advantage over the commercial LS com-
positions.
CONCLUSIONS AND PERSPECTIVES
Fluorescence images and GIXD experiments provide deﬁ-
nite evidence that contacting a DPPC monolayer with certain
FC gases results in a very effective ﬂuidization of the mono-
layer. FC gases prevent the formation of LC domains upon
compression of the DPPC monolayer. FC gases are also able
to induce the dissolution of LC domains when such domains
are already constituted and thus facilitate the respreading
of the DPPC molecules in an LE phase. This ﬂuidizing ef-
fect is fully reversible. These results suggest that FC gases/lipid
combinations may provide a useful basis for the design of
novel and synthetic LS compositions. The administration of
combinations of DPPC (or mixtures of lipids) and a gFC
could be conveniently achieved using pressurized meter dose
inhalers.
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